Empower Veterans Program (EVP): a chronic pain management program demonstrates positive outcomes among veterans
BMC Health Services Research volume 23, Article number: 431 (2023)
Chronic pain is a highly prevalent health condition among veterans. Traditional pharmacological interventions present unique challenges for chronic pain management including prescription opioid addiction and overdose. In alignment with the 2016 Comprehensive Addiction and Recovery Act and VA’s Stepped Care Model to meet veterans’ pain management needs, the Offices of Rural Health and Pain Management, Opioid Safety, and Prescription Drug Monitoring Program (PMOP) funded an enterprise-wide initiative to implement a Step 3 integrated tele-pain program: Empower Veterans Program (EVP). EVP provides veterans with chronic pain self-care skills using a whole health driven approach to pain management.
The Comprehensive Addiction and Recovery Act prompted the strategic approach to offer non-pharmacological options to meet veterans’ pain management needs. EVP, a 10-week interdisciplinary group medical appointment, leverages Acceptance and Commitment Therapy, Mindful Movement, and Whole Health to provide veterans with chronic pain self-care skills. This evaluation was conducted to describe participant characteristics, graduation, and satisfaction rates; and assess pre-post patient-reported outcomes (PRO) associated with EVP participation.
A sample of 639 veterans enrolled in EVP between May, 2015 and December, 2017 provided data to conduct descriptive analyses to assess participant demographics, graduation, and satisfaction rates. PRO data were analyzed using a within-participants pre-post design, and linear mixed-effects models were used to examine pre-post changes in PRO.
Of 639 participants, 444 (69.48%) graduated EVP. Participant median program satisfaction rating was 8.41 (Interquartile Range: 8.20–9.20). Results indicate pre-post EVP improvements (Bonferroni-adjusted p < .003) in the three primary pain outcomes (intensity, interference, catastrophizing), and 12 of 17 secondary outcomes, including physical, psychological, health-related quality of life (HRQoL), acceptance, and mindfulness measures.
Data suggest that EVP has significant positive outcomes in pain, psychological, physical, HRQoL, acceptance, and mindfulness measures for veterans with chronic pain through non-pharmacological means. Future evaluations of intervention dosing effect and long-term effectiveness of the program is needed.
Chronic pain affects an estimated 50 million American adults. [1, 2] The effects of chronic pain are far reaching, as it often persists beyond 3-to-6 months  from onset and encompasses physical, psychological, and social (biopsychosocial) components.  As such, over a third of individuals with chronic pain experience significant disability or interference with their activities of daily living and life roles. [1, 5]
Compared to the general population, veterans are disproportionately impacted by chronic pain and associated impairments, with higher prevalence of overall (29.1% v. 19.5%) and high-impact chronic pain (9.1% v. 6.4%) [1, 6]. Furthermore, combat veterans are at greater risk of experiencing chronic pain, with prevalence as high as 81.5% among Operation Enduring Freedom and Iraqi Freedom veterans.  The veteran chronic pain disparity is particularly problematic because mental health (e.g., depression, anxiety, sleep) and substance use disorders are common comorbidities among people with chronic pain. [8, 9] Moreover, Ilgen and colleagues observed a dose-response relationship between pain severity and completed suicide among veterans even when controlling for demographic and psychiatric characteristics.  Consequently, chronic pain has been designated a high priority area within the Department of Veterans Affairs (VA) system. [11, 12]
The emphasis of screening and assessing pain as the “fifth vital sign” unintentionally led to an increased reliance on prescription opioids to treat chronic pain. The increased use of prescription opioids for chronic pain management contributed to a national opioid epidemic marked by increased rates of opioid addiction, overdose, and mortality. [13,14,15,16] In response to the opioid crisis, the Comprehensive Addiction and Recovery ACT (CARA) re-oriented VA’s mission towards interdisciplinary programs from traditional healthcare models to decrease reliance on opioid prescriptions for chronic pain management.  Subsequent initiatives demonstrate the VA’s commitment to conducting research on the integration of non-pharmacological interventions for chronic pain management. Non-pharmacological interdisciplinary models, consisting of integrated providers from psychology, physical therapy, nursing, etc. are a whole health (WH) and wellbeing approach to chronic pain management treatment compared to usual healthcare. [18, 19]
The pathways for experiencing and treating chronic pain are complex as nociception is not necessary for pain to occur. [20, 21] Therefore, contemporary treatment models, such as Acceptance and Commitment Therapy (ACT), target chronic pain as a biopsychosocial condition instead of treating physiological pain intensity alone. [11, 22, 23] Through the ACT model an individual explores willingness to live a high quality of life, irrespective of chronic pain discomfort, through value-driven actions (e.g., returning to work, family roles). This approach focuses on improving overall functioning, indirectly reducing pain interference. [24, 25] ACT has shown promising results when other interventions focused on pain reduction achieve limited success. [25, 26]
The importance of increasing veteran access to non-pharmacological, integrated chronic pain programs is well-established. [27,28,29] The Empower Veterans Program (EVP) is an interdisciplinary chronic pain rehabilitation program with the ACT model as its core behavioral therapy. EVP expands beyond ACT to integrate mindful movement (MM) and WH. An EVP pilot examined 67 graduates for pre-post EVP improvements on clinical outcomes including pain intensity, catastrophizing, and health-related quality of life (HRQoL).  Clinical improvements were in the medium-to-large effect size range, with high satisfaction rates.  These findings were comparable to other large-scale non-pharmacological integrated chronic pain programs conducted in the VA system. [27, 31] Early EVP results indicate this program as a viable option to provide veterans with accessible and sustainable integrated non-pharmacological rehabilitation for chronic pain. [30, 32]
This paper follows a cohort of Veterans who completed EVP at a large VA Medical Center in the southeast who were unresponsive to and/or declining medications, procedures, and sequential monotherapies such as Cognitive-Behavioral Therapy (CBT) and Physical Therapy. In this paper we report on pre-post changes in patient-reported outcomes (PRO). Pain-related measures represent the primary outcome; physical, psychological, social, HRQoL, acceptance, and mindfulness measures represent secondary outcomes. The objective of this paper is to report on the preliminary effectiveness of EVP in this cohort and to describe the fit of EVP in the VA’s overall mission to provide innovative non-pharmacological strategies for chronic pain management and functional rehabilitation.
EVP cohorts range from 3 to 20 veterans that meet in-person weekly, for 10 consecutive weeks. Each meeting comprises of three, one-hour group sessions incorporating ACT, WH, and MM evidence-informed therapies. A total of 30 modules are facilitated by trained professionals (ACT – Psychologists; MM – Physical Therapists; WH – Chaplains) and incorporate topic areas including values and personal choices, mindful awareness training to notice thoughts and stressful emotions, safe movements, sleep, nutrition, and practices of compassion and gratitude. During each session, facilitators utilize scripts to engage participants in experiences that reinforce the main objectives presented in each module. Veteran activities included worksheet assignments, EVP Mindful Awareness and Compassion exercises on CD, handouts, video clips, group discussions, self-observations, and mobility exercises (simplified Yoga, Tai Chi). At-home practices are recommended to apply EVP strategies to daily life. In addition to program attendance, an EVP Chaplain conducts individual weekly follow-up coaching calls using motivational interviewing informed reflection. Though the program uses a standardized approach to optimize fidelity, EVP is designed to deliver a personalized experience to help veterans to confidently live fuller lives, usually with less pain, based on their individual values. A breakdown of EVP sessions by therapy type is shown in Table 1.
Design and sample
A within-participants pre-post design was used to examine PRO changes from week 1 (baseline) and the end of the program at week 10 (post-EVP). A cohort of 774 veterans with chronic pain were referred to EVP between May 2015 and December 2017. In total, 639 of these veterans (89.20%) enrolled in EVP and participated during this evaluation time period; final primary analyses included 617 veterans (79.72%) that completed PRO measures for at-least 1 time point and were included in final analyses. Figure 1 presents a flow diagram of veteran sampling.
Data was collected at a VA medical center in the southeastern United States. Standardized PRO measures were administered at the beginning of week 1 (baseline) and again at week 10 (post-EVP). Participant data were stored in Excel version 2201 spreadsheets on a secure drive behind the VA firewall. The data collection protocol was reviewed for ethical compliance by the Emory University Institutional Review Board and deemed non-research and was conducted as a quality management project. All veterans provided informed consent prior to their participation.
Given the preliminary quality management nature of this evaluation, exploratory measures including EVP graduation status and satisfaction rates were examined. To operationalize EVP graduation rate, we adopted the clinical requirements for the program. Specifically, participants that graduated from EVP completed ≥ 80% of sessions (≥8/10) and non-graduates completed less than ≤ 80% of EVP sessions (≤ 7/10). Primary pain-related outcomes (intensity, interference, catastrophizing), as well as secondary outcomes including physical health (functioning, fatigue), psychological health (depression, anxiety, sleep disturbance), social, HRQoL (physical, psychological, social, environmental), acceptance (activities engagement, pain willingness), and mindfulness were examined using validated PRO measures (Table 2).
Means and standard deviations were used to describe continuous data. Categorical data were presented using frequencies and percentages. The median (mdn) and interquartile range (IQR) were used to describe program satisfaction which was negatively skewed. Age was mean-centered and race was dichotomized (white/non-white) for analyses. Separate logistic regression models were used to compare demographic characteristics between survey responders and non-responders at each time point (baseline, post-EVP). Survey responders were defined as responding to at-least one survey at either specified time point. Mean scale scores were calculated and used for analysis for each PRO if ≥ 70% of scale items were completed at a given time point.  Of note, The brief World Health Organization Quality of Life Scale (WHOQoL-BREF) was not scored if ≥ 20% of data is missing as instructed in its manual.  Of note, a standardized WHOQoL-BREF scoring approach was used.  With the exception of social HRQoL, using standardized scores in the primary analyses produced non-positive definite matrices which produce unreliable results. Mean scores were used for the remaining HRQoL scales which resulted in model convergence.
Demographic characteristics including age, gender, and race were examined as predictors of graduation rate which is consistent with disparities in intervention engagement noted in previous research.  No a priori hypotheses were specified for the effects of demographic characteristics on PRO measures. Analysis of participant demographics were conducted at each time point to determine which characteristics to include as covariates in the primary analyses. Pearson correlations were calculated to examine the associations between age and PRO measures. Independent samples t-tests and one-way analysis of variance (ANOVA) models were conducted to examine the associations between categorical demographic characteristics and PRO measures. For preliminary analyses, to determine possible covariates for the primary analyses a p-value of 0.05 was used to determine statistical significance.
A logistic regression model was used to examine whether demographic characteristics predict the odds of participants graduating from EVP. The Hosmer Lemeshow test was used to assess goodness of fit for the logistic regression model. A Mann-Whitney U-Test was used to examine whether post-EVP satisfaction rates were significantly higher among EVP graduates versus non-graduates.
To assess pre-post EVP changes, separate linear-mixed models (LMMs) were fit for each PRO measure. The LMMs used an auto-regressive covariance matrix with maximum likelihood estimation. Mixed models can handle unbalanced data by making use of available information when outcome data is missing at a time point, thus preserving sample size. [44, 45] To establish base models to test hypotheses, random intercepts were fit to each model to account for the within-participant correlations between baseline and post-EVP measurements. All base models included time (baseline, post-EVP), graduation (graduates, non-graduates), and their interaction as fixed effects. Non-significant interactions were dropped from the model because of potential multicollinearity impacting standard errors (inflating). Independent variables were analyzed using planned contrasts. For the time variable, baseline was coded positively (+ 0.5) and post-EVP scores were coded negatively (-0.5). For interpretation of this coding scheme, a negative time coefficient indicates a decrease from baseline to post-EVP while a positive coefficient shows an increase. For graduation, EVP graduates were expected to have more positive PRO outcomes and were coded positively (+ 0.5) while non-graduates were expected to have worse PRO scores and thus, were coded negatively (-0.5). When demographic covariates were significantly associated with PRO measures (see preliminary analyses), the specific demographic variable and its interactions with time and graduation were also examined as fixed effects. In such models, non-white individuals and females were coded negatively (-0.5) consistent with previous research indicating worse pain presentations compared to white individuals and males (coded + 0.5), respectively. [43, 46] For analyses that examined race as a predictor variable, missing race cases were excluded from analyses (n = 6). Significant covariates were retained while non-significant covariates were dropped from respective models. Overall fit for model comparisons was examined using Akaike’s Information Criterion. To account for family-wise error rate associated with multiple comparisons, Bonferroni corrections were applied to the 20 primary and secondary outcomes. A conservative Bonferroni-adjusted p-value of (0.05/20 = 0.0025) was used to determine statistical significance for analyses of all primary and secondary outcomes. Analyses were conducted using SPSS version 27. Standardized mean differences (SMD) for correlated samples were calculated using a Microsoft Excel macro developed by Lakens.  The macro first calculates Cohen’s d and then applies a Hedges’ g correction to minimize positive bias for the sample estimate.  Effect sizes for Cohen’s d and Hedges g were adopted from a recent meta-analysis of chronic pain interventions that aim to enhance positive affect rather than reduce negative affect (e.g., ACT, mindfulness): ≤0.32 = small; 0.33-0.55 = moderate; ≥0.56 = large .
EVP participants (n = 639) ranged from 24 to 88 years old (m = 56.15 ± 10.75), were primarily male (70.89%), Black or African American (74.65%), identified as Christian (76.53%), and had VA service-connected disability (81.06%). Participant demographic characteristics by graduation status or EVP program completion are presented in Table 3.
Of the 639 participants, 570 (89.20%) provided baseline data, whereas 393 (61.50%) responded post-EVP, and 346 (54.15%) responded at both time points. Separate logistic regression models found no demographic differences between responders and non-responders at baseline (p = .464-.986) or at post-EVP (p = .169-.899).
Pearson correlations revealed no significant associations between age and any PRO outcomes (p = .055-0.975). Independent-samples t-tests revealed that baseline Patient-Reported Outcome Measurement Information System (PROMIS-29) sleep disturbance scores were 0.211 points higher among females than males (p = .020). No other differences were observed by gender (p = .079-0.961) or service-connected disability status (p = .078-.980). One-way ANOVA models did not reveal significant differences in PRO between religious groups (p = .067-0.978). Due to observed gender differences on PROMIS-29 sleep scores, gender was examined as a possible predictor of sleep disturbance.
Several potential differences were observed between white and non-white participants. On average, white participants had lower baseline scores on Chronic Pain Acceptance Questionnaire activity engagement (p = .013), WHOQoL-BREF psychological subscale (p = .040), as well as three Five-Facet Mindfulness Questionnaire (FFMQ) scales including acting with awareness (p = .011), describing self-experiences (p = .022), and non-reactivity to negative thoughts and emotions (p = .033). On average, white participants also had higher PROMIS-29 anxiety scores at baseline (p = .049) and post-EVP (p = .047). No other race differences were observed (p = .10-0.86). This pattern of results indicated that white participants may have experienced more negative outcomes than non-white participants, as such race (white v. non-white) was chosen as a possible predictor in each PRO model comparison.
In total, 444 participants (69.48%) graduated from EVP. A logistic regression model was used to examine whether graduating from EVP was associated with demographic characteristics. The Hosmer Lemeshow test indicated that this model adequately fit the data χ2(8) = 5.041, p = .753. Participant age (p < .001) and race (p = .008) were significantly associated with graduation status, but not gender (p = .399), religion (p = .676), or service-connected disability (p = .981). Each one-year increase in age was associated with a 3.1% increase in the odds of being an EVP graduate versus a non-graduate, OR = 1.031, 95% confidence interval (CI; 1.014, 1.049). White participants were 43.4% less likely to graduate from EVP than non-white participants, OR = 0.566, 95% CI (0.372, 0.862), but the effect size for this model was small, Cox and Snell R2 = 0.036.
Post-EVP satisfaction rates were examined using the Pain Outcomes Questionnaire-VA 0–10 scale. EVP satisfaction rate scores had a range from 3.20 to 9.80. The median EVP score was 8.41 points with an IQR from 8.20 to 9.20. A Mann-Whitney U test found that overall, post-EVP satisfaction rates did not differ between graduates and non-graduates, U = 5063.50, p = .081.
The PRO models primarily focused on the predictors included in the base models including fixed main effects of time, graduation, and their interaction. None of the models produced a significant time x graduation interaction effect after accounting for the Bonferroni-adjusted significance threshold. Non-significant time by graduation interaction terms were excluded from the final models because of potential multicollinearity inflating standard errors. Results from the LMMs are presented in Table 4.
Main effects of time and graduation
The main effect of time was indicative that PROs significantly changed from baseline to post-EVP. Estimated marginal means and effect sizes for PROs at each time point are reported (see table, Supplementary File 1). Pain (Primary): Participants reported decreases for all three pain-related PROs (p < .001) including intensity (SMD = − 0.199), interference (SMD = − 0.448), and catastrophizing (SMD = − 0.392) with effect sizes in the small-to-medium range (see plots, Supplementary Files 2–4). Physical: Participants’ fatigue (p < .001, SMD = -.300) decreased from baseline to post-EVP, but surprisingly so did their physical functioning scores (p < .001, SMD = -.175). Both effect sizes were small. Psychological: Participants’ anxiety (SMD = − 0.233), depression (SMD = − 0.430), and sleep disturbance (SMD = − 0.218) scores all decreased from baseline to post-EVP (p < .001) indicating small-to-medium effect sizes. Social: Participants social health scores unexpectedly decreased (p < .001, SMD = − 0.260) from baseline to post-EVP indicating a small effect. HRQoL: Physical (SMD = 0.417), psychological (SMD = 0.279), social (SMD = 0.260), and environmental (SMD = 0.188) HRQoL scores all increased from baseline to post-EVP (p < .001). Effect sizes in the small-to-medium range. Acceptance: Participants reported increased engagement in life activities despite pain (p < .001, SMD = 0.779) indicating a large effect. They also experienced a small effect size improvement in willingness to experience pain without attempts to control it (p < .001, SMD = 0.320). Mindfulness: For FFMQ mindfulness domains participants experienced small effect size improvements in non-reactivity to negative thoughts/emotions (p < .001, SMD = 0.178) and observing their experiences (p < .001, SMD = 0.173). This was not the case for describing their own experiences (p = .200), non-judgement scores (p = .105), and acting with awareness in the moment (p = .014), with the latter effect not meeting the Bonferroni-adjusted significance threshold. With the exception of the decrease in physical functioning and social scores, this pattern of significant main effects reflects positive improvements from baseline to post-EVP. Contrary to expectations, there were no significant graduation effects in these in any of the LMMs after the Bonferroni-correction was applied (p = .032-0.998).
Main effects of race and gender
Main effects of race are indicative of PROs differing between white and non-white participants. Race and gender-based main effects were considered exploratory and dropped from LMMs when non-significant. Psychological: Gender was a non-significant predictor of sleep disturbances (p = .085) and dropped from this LMM. Non-white participants (m = 2.839) reported lower anxiety scores than white participants (m = 3.102), p = .011. Social: Non-white participants (m = 3.598) PROMIS-29 scale scores indicated lower social health than white participants (m = 3.788), p = .034. HRQoL: Non-white participants (m = 11.983) had higher psychological HRQoL scores than white participants (m = 11.186), p = .016. Acceptance: On average, non-white participants (m = 3.007) had activity engagement scores that were higher than white participants (m = 2.749), p = .017. Mindfulness: FFMQ acting with awareness scores were higher among non-white participants (m = 3.216) than white participants (m = 2.982), p = .009. Using a more traditional significance threshold (p < .05) would have yielded a pattern of race-based main effects that typically indicated more favorable PROs for non-white than white participants. However, none of these race effects met criteria for statistical significance using the more conservative Bonferroni-adjusted threshold (p = .0025).
The national response to the opioid epidemic and veteran suicide demands effective non-pharmacological treatments to alleviate chronic pain for veterans. Innovations such as EVP are emerging to support chronic pain management for this priority population. Data is needed to determine the effects of such programs on a spectrum of outcomes. Preliminary data indicate EVP has significant positive outcomes on pain, physical, psychological, HRQoL, acceptance, and mindfulness measures for Veterans with chronic pain. Interestingly, there were no significant graduation improvements which is best explained by the non-granular, binary nature of graduation data and possible variance captured by other model variables (e.g., Acceptance, Mindfulness, HRQoL) that are part in parcel to EVP attendance and ultimately graduation. Our study design and analyses did capture overall health effects, however the weekly attendance of ACT, MM, and WH, each a 1-hour session for 3 hours per week were not recorded. Hence, these data warrant further investigation into the potential dosing effect of the specific EVP components beyond a simple binary measure of program completion. While the effect size was small, it is notable that results indicated that higher age and non-white race were significantly associated with increased likelihood of completing EVP (i.e., graduation). Though satisfaction scores had a wide range (3.2–9.8), the median and IQR indicate that scores were high and did not differ between EVP graduates versus non-graduates. These findings provide some indication that the program is acceptable and useful for diverse audiences.
Results suggest PROs significantly changed from baseline to post-EVP. Primary pain outcomes (pain intensity, interference, catastrophizing) decreased from baseline to post-EVP with medium effect sizes improvement being observed for pain interference and catastrophizing and a small effect for intensity. Using the effect size criteria from the current study, findings from other interdisciplinary chronic pain rehabilitation programs in the VA system found medium (catastrophizing) to large (intensity, interference) within-participant effect sizes.  A separate study examining the VA inpatient chronic pain rehabilitation program found a similar pattern of significant effects with these primary outcomes, but effect sizes were not reported for comparison.  Of note, the former findings  were aggregated across inpatient and outpatient programs that typically operated on cognitive behavioral-based models. Thus, it is a non-equivalent comparison.
Results also indicated positive outcomes on most secondary measures. Physical (fatigue), psychological (anxiety, depression, sleep disturbance), and HRQoL measures (environmental, physical, psychological, social, environmental) improved from baseline to post EVP. Moreover, we observed notable improvements in acceptance (activities engagement, pain willingness) and mindfulness (non-reactivity, observation) measures which provide support for the theoretical foundations of EVP (i.e., ACT, MM). A meta-analysis of group ACT for chronic pain indicated small-to-large between-participant effect size improvements for overall pain acceptance post-treatment versus a heterogenous array of control conditions.  The current study examined acceptance as two CPAQ sub-scales rather than as a total score. While, the observed within-participant large effect for activity engagement and small effect size for pain willingness were similar in magnitude to previous findings, the pre-post SMD comparison differs from the between-group designs. We were able to make a comparison with EVP and CBT for chronic pain for depression and HRQoL sub-domains. Murphy and colleagues  found large within-participant improvements for depression and physical HRQoL as well as medium effects for psychological, social, and environmental HRQoL from pre-post CBT for chronic pain. The current study observed medium within-participant effect size improvements for depression and physical HRQoL as well as small effects for psychological, social, and environmental HRQoL. While the CBT study found larger effect sizes in a VA sample, these interventions vary by their primary theoretical foundation (i.e., CBT v. ACT).
There were unanticipated observed decreases in PROMIS-29 physical functioning and social subscale scores. These findings were seemingly contradictory to observed improvements in physical and social HRQoL. This seems to be an anomaly from this preliminary data sample but warrants further investigation in larger subsequent trials. Collectively findings indicate the holistic benefit of the interdisciplinary approach of EVP.
Though findings are favorable, several limitations should be considered when interpreting results. First, these data represent a limited sample from a single VA facility in an urban setting within the southeast. Additional data should be examined as EVP expands to additional VA sites. Though the sample represents a predominantly urban population, the fairly recent transition to remote delivery of TelePain-EVP will also increase veteran engagement in rural areas. Second, dosing of EVP using attendance data from participation for each of EVP’s subcomponents (ACT, MM, WH) is needed; current data collection efforts are underway. Third, as EVP is a clinical quality management effort, recruitment was based on the pragmatic referral approach rather than randomization, representing a potential self-selection bias, and a referral bias, as mental health providers were responsible for most EVP referrals. Moreover, veterans referred to comprehensive Step 3 pain care programs (i.e., EVP) typically have not responded well to previous steps of pain care (e.g., primary care, specialty pain care) and present with additional complex issues (e.g., depression, opioid use, possible suicidality secondary to pain).  Thus, identifying an adequate control group for this unique population is very difficult and under certain circumstances unethical (e.g., suicidality). Fourth, confounding factors were not fully addressed, including evolving guidance for chronic pain management (e.g., decreasing trend in opioid prescriptions), and potentially concurrent services (e.g., CBT, WH/Complementary and Integrative Healthcare services). Fifth, self-report bias which is intrinsic to PRO measures is another limitation of this study. Future studies should integrate objective outcome measures to validate these findings.
Future efforts will benefit from emphasis a larger multi-site sample within the expansion of EVP. Replicability of EVP at additional VA facilities can now be evaluated as the program is being implemented at multiple VA facilities. Subsequent evaluations should include long-term re-assessment of PRO measures, as well as balancing measures (e.g., balanced scorecard or dashboard) to assess other domains to assess unintended consequences. In the response to the COVID-19 pandemic, the VA prioritized expanding veteran access to telehealth services, most recently with Tele-pain services. [52, 53] As such, the potential impact of the recent implementation of TelePain-EVP as a remotely delivered telehealth program is currently being evaluated. To build on current knowledge, future evaluation efforts will also assess dosing effects, the relationship between EVP engagement and medication use, and survival analyses - given the risk of this population for morbidity and mortality, including suicidality. [10, 51]
As healthcare systems follow the VA’s lead in seeking non-pharmacological treatments to alleviate chronic pain, interdisciplinary programs such as EVP are emerging to support these efforts. Preliminary data suggest Veterans with chronic pain who participate in the EVP program report significant positive outcomes in pain, physical, psychological, HRQoL, acceptance, and mindfulness measures. Though findings are compelling, future evaluations should focus on evaluating larger sample datasets, dosing effects, and effectiveness of the program using a telehealth model to inform ongoing implementation and spread of the EVP program.
The datasets developed and/or analyzed during the current project available from the corresponding author on reasonable request.
Acceptance and Commitment Therapy
Analysis of Variance
Comprehensive Addiction and Recovery ACT
Chronic Pain Acceptance Questionnaire
Empower Veterans Program
Five-Facet Mindfulness Questionnaire
Health-Related Quality of Life
Linear Mixed Models
Motion is Lotion Exercises
Pain Outcomes Questionnaire–Veterans Affairs
Pain Catastrophizing Scale
Pain, Enjoyment, and General Activity Scale
Patient Health Questionnaire-9
Offices of Rural Health and Pain Management, Opioid Safety, and PDMP
Patient-Reported Outcome Measurement Information System
Standardized Mean Difference
Department of Veterans Affairs
World Health Organization Quality of Life Scale
Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001–6. https://doi.org/10.15585/mmwr.mm6736a2
Simon LS. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. J Pain Palliat Care Pharmacother. 2012;26(2):197–8. https://doi.org/10.3109/15360288.2012.678473
Grichnik KP, Ferrante FM. The difference between acute and chronic pain. Mt Sinai J Med N Y. 1991;58(3):217–20.
Merskey H, Albe Fessard D, Bonica J, et al. Pain terms: a list with definitions and notes on usage. Recommended by the IASP subcommittee on taxonomy. Pain. 1979;6(3):249–52.
Pitcher MH, Von Korff M, Bushnell MC, Porter L. Prevalence and profile of high-impact chronic pain in the United States. J Pain. 2019;20(2):146 – 60. doi10.1016/j.jpain.2018.07.006
Nahin RL. Severe pain in veterans: the effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247–54. https://doi.org/10.1016/j.jpain.2016.10.021
Lew HL, Otis JD, Tun C, et al. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev. 2009;46(6):697–702. https://doi.org/10.1682/jrrd.2009.01.0006
Higgins DM, Kerns RD, Brandt CA, et al. Persistent pain and comorbidity among Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn Veterans. Pain Med. 2014;15(5):782–90. https://doi.org/10.1111/pme.12388
Becker WC, Fiellin DA, Gallagher RM, et al. The Association between Chronic Pain and prescription drug abuse in Veterans. Pain Med. 2009;10(3):531–6. https://doi.org/10.1111/j.1526-4637.2009.00584.x
Ilgen MA, Zivin K, Austin KL, et al. Severe Pain predicts Greater Likelihood of subsequent suicide. Suicide Life Threat Behav. 2010;40(6):597–608. https://doi.org/10.1521/suli.2010.40.6.597
Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline For Opioid Therapy For Chronic Pain; 2017. Accessed July 1, 2018. https://www.healthquality.va.gov/guidelines/Pain/cot/VADoDOTCPG022717.pdf
Becker WC, DeBar LL, Heapy AA, et al. A research agenda for advancing non-pharmacological management of chronic musculoskeletal pain: Findings from a VHA State-of-the-art conference. J Gen Intern Med. 2018;33(S1):11–5. https://doi.org/10.1007/s11606-018-4345-6
Bohnert ASB, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–21. https://doi.org/10.1001/jama.2011.370
Lin L, Peltzman T, McCarthy JF, et al. Changing trends in opioid overdose deaths and prescription opioid receipt among veterans. Am J Prev Med. 2019;57(1):106–10. https://doi.org/10.1016/j.amepre.2019.01.016
Chua KP, Brummett CM, Conti RM, Bohnert A. Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults. JAMA Pediatr. 2020;174(2):141–8. https://doi.org/10.1001/jamapediatrics.2019.4878
Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US Veterans of Iraq and Afghanistan. JAMA. 2012;307(9). https://doi.org/10.1001/jama.2012.234
Comprehensive Addiction and Recovery Act. 2016. Accessed May 12, 2022. https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf
Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ. 2015;350(feb18 5):h444–4. https://doi.org/10.1136/bmj.h444
Abbey H. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. Int J Osteopath Med. 2015;18(3):239–40. https://doi.org/10.1016/j.ijosm.2015.07.008
Moseley GL, Vlaeyen JWS. Beyond nociception: the imprecision hypothesis of chronic pain. Pain. 2015;156(1):35–8. https://doi.org/10.1016/j.pain.0000000000000014
Butler DS, Moseley GL. Explain Pain Bertrams. 2013. Accessed November 29, 2021. http://www.vlebooks.com/vleweb/product/openreader?id=none&isbn=9780987342676
Driscoll MA, Edwards RR, Becker WC, Kaptchuk TJ, Kerns RD. Psychological interventions for the treatment of chronic pain in adults. Psychol Sci Public Interest. 2021;22(2):52–95. https://doi.org/10.1177/15291006211008157
Wetherell JL, Afari N, Rutledge T, et al. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain. 2011;152(9):2098–107. https://doi.org/10.1016/j.pain.2011.05.016
Hayes SC, Duckworth MP. Acceptance and commitment therapy and traditional cognitive behavior therapy approaches to pain. Cogn Behav Pract. 2006;13(3):185–7. https://doi.org/10.1016/j.cbpra.2006.04.002
McCracken LM, Vowles KE. Acceptance and commitment therapy and mindfulness for chronic pain: Model, process, and progress. Am Psychol. 2014;69(2):178–87. https://doi.org/10.1037/a0035623
Vowles KE, Fink BC, Cohen LL. Acceptance and commitment therapy for chronic pain: a diary study of treatment process in relation to reliable change in disability. J Context Behav Sci. 2014;3(2):74–80. https://doi.org/10.1016/j.jcbs.2014.04.003
Murphy JL, Palyo SA, Schmidt ZS, et al. The resurrection of interdisciplinary pain rehabilitation: outcomes across a Veterans Affairs collaborative. Pain Med. 2021;22(2):430–43. https://doi.org/10.1093/pm/pnaa417
Glynn LH, Chen JA, Dawson TC, Gelman H, Zeliadt SB. Bringing chronic-pain care to rural veterans: a telehealth pilot program description. Psychol Serv. 2021;18(3):310–18. https://doi.org/10.1037/ser0000408
Chen JA, DeFaccio RJ, Gelman H, et al. Telehealth and rural-urban differences in receipt of pain care in the Veterans Health Administration. Pain Med. 2022;23(3):466–74. https://doi.org/10.1093/pm/pnab194
Uche JU, Jamison M, Waugh S. Evaluation of the Empower Veterans Program for military veterans with chronic pain. J Clin Outcomes Manag. 2022;29(2):88–95. https://doi.org/10.12788/jcom.0089
Murphy JL, Clark ME, Banou E. Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment. Clin J Pain. 2013;29(2):109–17. https://doi.org/10.1097/AJP.0b013e3182579935
Penney LS, Haro E. Qualitative evaluation of an interdisciplinary chronic pain intervention: outcomes and barriers and facilitators to ongoing pain management. J Pain Res. 2019;12:865–78. https://doi.org/10.2147/JPR.S185652
Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733–38. https://doi.org/10.1007/s11606-009-0981-1
Cella D, Riley W, Stone A, et al. The patient-reported outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–94. https://doi.org/10.1016/j.jclinepi.2010.04.011
Sullivan MJL, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess. 1995;7(4):524–32. https://doi.org/10.1037/1040-35220.127.116.114
Kroenke K, Spitzer RL. The PHQ-9: a New Depression Diagnostic and Severity measure. Psychiatr Ann. 2002;32(9):509–15. https://doi.org/10.3928/0048-5713-20020901-06
The Whoqol Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychol Med. 1998;28(3):551–58. https://doi.org/10.1017/S0033291798006667
McCracken LM, Vowles KE, Eccleston C. Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004;107(1):159–66. https://doi.org/10.1016/j.pain.2003.10.012
Baer RA, Smith GT, Hopkins J, Krietemeyer J, Toney L. Using self-report assessment methods to explore facets of mindfulness. Assessment. 2006;13(1):27–45. https://doi.org/10.1177/1073191105283504
Clark ME, Gironda RJ, Young RW. Development and validation of the Pain Outcomes Questionnaire-VA. J Rehabil Res Dev. 2003;40(5):381–95. https://doi.org/10.1682/jrrd.2003.09.0381
Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018;319(9):872–82. https://doi.org/10.1001/jama.2018.0899
Harper A, Power M. WHOQOL User Manual. World Health Organization, 2012. Accessed August 15, 2022. https://www.who.int/publications/i/item/WHO-HIS-HSI-Rev.2012-3
Bhimani RH, Cross LJS, Taylor BC, et al. Taking ACTION to reduce pain: ACTION study rationale, design and protocol of a randomized trial of a proactive telephone-based coaching intervention for chronic musculoskeletal pain among African Americans. BMC Musculoskelet Disord. 2017;18(1):15–28. https://doi.org/10.1186/s12891-016-1363-6
Grund S, Lüdtke O, Robitzsch A. Multiple imputation of missing data for multilevel models: simulations and recommendations. Organ Res Methods. 2018;21(1):111–49. https://doi.org/10.1177/1094428117703686
Van Buuren. Flexible Imputation of Missing Data, Second Edition. Routledge, 2018.
Kaur S, Stechuchak KM, Coffman CJ, Allen KD, Bastian LA. Gender differences in health care utilization among veterans with chronic pain. J Gen Intern Med. 2007;22(2):228–33. https://doi.org/10.1007/s11606-006-0048-5
Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:1–12. https://doi.org/10.3389/fpsyg.2013.00863
Ong AD, Thoemmes F, Ratner K, Ghezzi-Kopel K, Reid MC. Positive affect and chronic pain: a preregistered systematic review and meta-analysis. Pain. 2020;161(6):1140–9. https://doi.org/10.1097/j.pain.0000000000001828
Hughes LS, Clark J, Colclough JA, Dale E, McMillan D. Acceptance and Commitment Therapy (ACT) for chronic pain: a systematic review and meta-analyses. Clin J Pain. 2017;33(6):552–68. https://doi.org/10.1097/AJP.0000000000000425
Murphy JL, Cordova MJ, Dedert EA. Cognitive behavioral therapy for chronic pain in veterans: evidence for clinical effectiveness in a model program. Psychol Serv. 2022;19(1):95–102. https://doi.org/10.1037/ser0000506
Ward R, Rauch SAM, Axon RN, Saenger MS. Evaluation of a non-pharmacological interdisciplinary pain rehabilitation and functional restoration program for chronic pain in veterans. Health Serv Res. 2022;1–10. https://doi.org/10.1111/1475-6773.14062
Connolly SL, Stolzmann KL, Heyworth L, et al. Rapid increase in telemental health within the Department of Veterans Affairs during the COVID-19 pandemic. Telemed E-Health. 2021;27(4):454–8. https://doi.org/10.1089/tmj.2020.0233
Office of Inspector General. Review of Veterans Health Administration’s COVID-19 Response and Continued Pandemic Readiness. Department of Veterans Affairs. ; 2020. Accessed August 20, 2020. https://www.va.gov/oig/pubs/VAOIG-20-03076-217.pdf
This operational quality management initiative for chronic pain was supported by numerous local, regional and national VHA personnel and offices including: EVP team-members past and present: Mary Elizabeth Hammons, Jennifer Gansen, Symeon Burholt, Ushvani Persaud, Jennifer DelVentura, Lindsay Ballengee, Drew Tomberlin, George Shaw, Curtis Williams, and all of the EVP team; AVAHCS staff: David Bower, former Chief of Staff, David Goldstrom, Chief of Chaplains, Anne Tomolo, former Associate Chief of Staff for Education; Leslie Wiggins, former Director of VHA Southeast Region (VISN7). This manuscript was supported in part by the James A Haley Veterans’ Hospital Research and Development Service. The contents of this manuscript do not represent the views of the Department of Veterans Affairs of the United States Government.
The Department of Veterans Affairs, Veterans Health Administration, Office of Rural Health (OMAT ID# 16403,16404, 16405, 16489, 16490); and the Pain Management, Opioid Safety and Prescription Drug Monitoring Program Office (PMOP ID# SP8E-PMTIA160) supported the development of this manuscript (Co-PI’s: Haun, Saenger). Early versions of this work (PI: Saenger) were supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Patient-Centered Care and Cultural Transformation (OPCCCT), and the Veterans Integrated Service Network − 7 (VISN 7).
Ethics approval and consent to participate
This quality management project was part of a larger on-going evaluation of the Empower Veterans Program that was deemed non-research by the Emory University Institutional Review Board and the Atlanta Veterans Affairs Medical Center Research and Development Committee. This quality management project was considered to pose no greater than minimal risk to its participants. All project methods were performed in accordance with the Declaration of Helsinki. During the recruitment process, veterans were notified of project objectives and confidentiality. All veterans provided informed consent prior to their participation.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Haun, J.N., Fowler, C.A., Venkatachalam, H.H. et al. Empower Veterans Program (EVP): a chronic pain management program demonstrates positive outcomes among veterans. BMC Health Serv Res 23, 431 (2023). https://doi.org/10.1186/s12913-023-09327-5